1. 1. Kägi, J. H. R. and Kojima, Y. (1987) : Chemistry and biochemistry of metallothioneins. p. 25-63. In J. H. R. Kagi and Y. Kojima (eds.) , Metallothioneins II. Birkhauser Verlag, Basel/Boston.
2. 2. Nachev, Ch. (1988) : Apometallothioneins and changes in the zinc and copper homeostasis in the etiopathogenesis of some pathological alterations. D. Sci. Thesis. Medical Academy, Sofia, Bulgaria. 148p.
3. 3. Nachev, Ch., Bontchev, P. R., Evtimova, B, and Ivanov, D. (1988) : Copper and zinc interaction with vasoconstrictors and vasodilators. J. Clin. Pharmacol., 28, 923.
4. 4. Bontchev, P. R., Nachev, Ch., Evtimova, B., Yordanov, N. D., Zhecheva, E. and Mehandjiev, D. (1989) : Copper (II) complexes of dihydralazine. Proc. 12th Conf. Coord. Chem., Smolenice, Czechoslovakia.
5. 5. Bontchev, P. R., Gochev, H., Evtimova, B., Kadum, H, and Nachev, Ch. (1992) : Copper (II) interaction and complexation with 1 [2 (S) -3-mercapto-3-methylpropionyl] -L-proline (Captopril) . J. Inorg. Biochem., 46, 23-34.